This weekly injectable medication combines the GLP-1 mimicking effects of semaglutide with the properties of the pancreatic hormone amylin
Never adjust your medication without professional guidance , as doing so may result in inadequate blood sugar control and potentially serious health consequences
Side effects with Wegovy 7.2 mg The STEP UP trial found that side effects were somewhat more common at the 7.2 mg dose than at 2.4 mg: 2 GI side effects: 70.8% (7.2 mg) vs 61.2% (2.4 mg) Dysaesthesia (tingling or numbness): 22.9% (7.2 mg) vs 6.0% (2.4 mg) Discontinuation due to side effects remained low at 3.3% The dysaesthesia finding is notable, though 85.7% of cases resolved while continuing treatment
The non-flavonoids include phenolic acids, aldehydes, acetophenones, phenylacetic acids, cinnamic acids, coumarins, biflavonyls, benzophenones, xanthones, stilbenes, and tannins 104